News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
131,260 Results
Type
Article (9890)
Company Profile (29)
Press Release (121340)
Multimedia
Podcasts (23)
Webinars (4)
Section
Business (39721)
Career Advice (287)
Deals (6156)
Drug Delivery (26)
Drug Development (12598)
Employer Resources (25)
FDA (3626)
Job Trends (3686)
News (64035)
Policy (6827)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (757)
Academic (1)
Accelerated approval (9)
ADA (2)
Adcomms (4)
Allergies (33)
Alliances (11956)
ALS (32)
Alzheimer's disease (264)
Antibody-drug conjugate (ADC) (80)
Approvals (3789)
Artificial intelligence (136)
ASCO (75)
Autoimmune disease (34)
Automation (37)
Bankruptcy (40)
Best Places to Work (2757)
BIO (4)
BIOSECURE Act (3)
Biosimilars (37)
Biotechnology (19)
Bladder cancer (58)
Brain cancer (10)
Breast cancer (200)
Cancer (1306)
Cardiovascular disease (77)
Career advice (256)
Career pathing (6)
CAR-T (68)
CDC (13)
Celiac Disease (1)
Cell therapy (150)
Cervical cancer (14)
Clinical research (10344)
Collaboration (498)
Company closure (1)
Compensation (40)
Complete response letters (10)
COVID-19 (867)
CRISPR (16)
C-suite (258)
Cystic fibrosis (17)
Data (1303)
Denatured (1)
Depression (9)
Dermatology (13)
Diabetes (65)
Diagnostics (3571)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (96)
Drug pricing (44)
Drug shortages (3)
Duchenne muscular dystrophy (34)
Earnings (12015)
Editorial (11)
Employer branding (10)
Employer resources (23)
Events (13460)
Executive appointments (258)
FDA (4265)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (292)
Gene editing (31)
Generative AI (9)
Gene therapy (149)
GLP-1 (184)
Government (1246)
Grass and pollen (3)
Guidances (75)
Healthcare (2807)
Hematology (49)
HIV (26)
Huntington's disease (9)
IgA nephropathy (20)
Immunology and inflammation (43)
Immuno-oncology (19)
Indications (42)
Infectious disease (961)
Inflammatory bowel disease (16)
Inflation Reduction Act (3)
Influenza (38)
Intellectual property (29)
Interviews (40)
IPO (1847)
IRA (15)
Job creations (1038)
Job search strategy (240)
JPM (20)
Kidney cancer (2)
Labor market (21)
Layoffs (114)
Leadership (6)
Legal (1493)
Liver cancer (14)
Longevity (7)
Lung cancer (186)
Lymphoma (103)
Machine learning (12)
Management (5)
Manufacturing (284)
MASH (16)
Medical device (1695)
Medtech (1705)
Mergers & acquisitions (4491)
Metabolic disorders (152)
mRNA (34)
Multiple sclerosis (24)
NASH (1)
Neurodegenerative disease (68)
Neuropsychiatric disorders (10)
Neuroscience (453)
NextGen: Class of 2026 (1017)
Non-profit (681)
Now hiring (24)
Obesity (66)
Opinion (72)
Ovarian cancer (34)
Pain (17)
Pancreatic cancer (34)
Parkinson's disease (36)
Partnered (7)
Patents (64)
Patient recruitment (57)
Peanut (16)
People (13675)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase 1 (2997)
Phase 2 (4121)
Phase 3 (4132)
Pipeline (1572)
Policy (64)
Postmarket research (546)
Preclinical (1528)
Press Release (18)
Prostate cancer (78)
Psychedelics (5)
Radiopharmaceuticals (96)
Rare diseases (153)
Real estate (2161)
Recruiting (11)
Regulatory (5098)
Reports (10)
Research institute (737)
Resumes & cover letters (42)
Rett syndrome (4)
RNA editing (1)
RSV (17)
Schizophrenia (18)
Series A (53)
Series B (31)
Sickle cell disease (17)
Special edition (8)
Spinal muscular atrophy (83)
Sponsored (11)
Startups (910)
State (1)
Stomach cancer (4)
Supply chain (35)
Tariffs (25)
The Weekly (22)
Vaccines (218)
Venture capital (32)
Weight loss (42)
Women's health (26)
Worklife (1)
Date
Today (17)
Last 7 days (74)
Last 30 days (407)
Last 365 days (4282)
2026 (2256)
2025 (4294)
2024 (5493)
2023 (6416)
2022 (11001)
2021 (11124)
2020 (10587)
2019 (7642)
2018 (5937)
2017 (6587)
2016 (6338)
2015 (7042)
2014 (5691)
2013 (4944)
2012 (5321)
2011 (5342)
2010 (4867)
Location
Africa (178)
Alabama (15)
Alaska (1)
Arizona (55)
Arkansas (2)
Asia (7935)
Australia (1300)
California (1775)
Canada (585)
China (125)
Colorado (85)
Connecticut (65)
Delaware (76)
Europe (19552)
Florida (230)
Georgia (29)
Idaho (9)
Illinois (141)
India (12)
Indiana (102)
Iowa (3)
Japan (91)
Kansas (30)
Kentucky (10)
Louisiana (8)
Maine (28)
Maryland (265)
Massachusetts (1281)
Michigan (111)
Minnesota (63)
Missouri (75)
Montana (10)
Nebraska (5)
Nevada (23)
New Hampshire (14)
New Jersey (730)
New Mexico (11)
New York (576)
North Carolina (312)
North Dakota (1)
Northern California (837)
Ohio (95)
Oklahoma (4)
Oregon (6)
Pennsylvania (251)
Puerto Rico (3)
Rhode Island (14)
South America (251)
South Carolina (7)
South Dakota (1)
Southern California (719)
Tennessee (43)
Texas (441)
United States (6960)
Utah (95)
Virginia (27)
Washington D.C. (9)
Washington State (146)
Wisconsin (31)
131,260 Results for "nova laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia
April 23, 2026
·
6 min read
Press Releases
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
March 25, 2026
·
8 min read
Press Releases
LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)
March 30, 2026
·
8 min read
Press Releases
Centinel Spine® Receives MDR Certification for prodisc® C Vivo and prodisc® C Nova Cervical Total Disc Replacement Systems
September 12, 2025
·
3 min read
Deals
Nova Research Laboratories, LLC announces acquisition of CiPA Lab
Nova Research Laboratories, LLC is pleased to announce the acquisition of Maryland-based CiPA Lab. Dr. Jason (Jiansong) Sheng, Ph.D., CEO of CiPA Lab, and his team will be a great benefit to expanding Nova’s preclinical capabilities.
April 3, 2023
·
2 min read
Press Releases
Patricia Industries’ subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
March 19, 2025
·
5 min read
Press Releases
DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa
April 29, 2025
·
5 min read
Press Releases
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
December 31, 2024
·
7 min read
Press Releases
Plus Therapeutics Announces CAP Accreditation of CNSide® Diagnostics Clinical Laboratory
June 4, 2026
·
7 min read
Press Releases
ARUP Laboratories Launches National Infectious Disease Test Positivity Trends Dashboard
May 13, 2026
·
2 min read
1 of 13,126
Next
